Daily Junction.mobi portalOver 100 supervised consumption rooms operate in Europe, Canada, and Australia, with no recorded overdose deaths inside the facilities. However, they remain illegal in the UK under the Misuse of Drugs Act 1971. A pilot facility in Glasgow has been approved in principle but cannot open without changes to UK law, which the Home Office has refused to support.
Drug checking services allow people to test the contents and purity of drugs before use, helping them avoid dangerous adulterants like fentanyl or nitazenes. They operate in the Netherlands, Switzerland, Austria, and Portugal, and have been shown to:
The UK has piloted drug checking at music festivals (The Loop), but these services are not available in community settings where most drug use occurs. Expanding drug checking could save lives by alerting users to the presence of nitazenes or other dangerous adulterants.
Naloxone (brand name Narcan) is an opioid overdose reversal medication that can save lives if administered quickly. It is available without prescription in the UK, and many areas have take-home naloxone programmes for people who use opioids and their families.
However, distribution is patchy and underfunded. A 2024 report by the National Naloxone Programme found that only 30% of people in opioid treatment had been offered take-home naloxone, and distribution to people not in treatment (who are at highest risk) was even lower.
Scotland has the most developed naloxone programme, with over 50,000 kits distributed since 2011, but even this is insufficient given the scale of the crisis. Expanding naloxone distribution—particularly higher-strength formulations needed to reverse nitazene overdoses—is an urgent priority.
The UK's drug policy is based on prohibition—the criminalisation of drug possession and supply under the Misuse of Drugs Act 1971. Supporters of prohibition argue it deters drug use and protects public health. Critics argue it has failed to reduce drug use, criminalises vulnerable people, and prevents evidence-based harm reduction measures.
Advocates for drug policy reform point to evidence from other countries:
In the UK, the Liberal Democrats and Green Party support decriminalisation, and the Labour Party has debated the issue, though it remains officially opposed. The Conservative government (2010-2024) rejected calls for reform, arguing that decriminalisation would send the "wrong message" and increase drug use.
Supporters of prohibition argue that:
However, the evidence for these claims is weak. Drug use rates in the UK are similar to or higher than countries with more liberal policies, and the rise in drug deaths suggests prohibition is not protecting public health.
The Labour government, elected in July 2024, has committed to a public health approach to drug policy, though it has ruled out decriminalisation. Key commitments include:
Health Secretary Wes Streeting has called drug deaths a "national scandal" and promised to "rebuild treatment services destroyed by a decade of cuts." However, he has also ruled out decriminalisation, stating in September 2024: "We will not legalise drugs. We will focus on treatment, prevention, and enforcement."
Critics argue this approach is insufficient. The Advisory Council on the Misuse of Drugs has called for supervised consumption rooms, drug checking services, and decriminalisation of possession for personal use as essential measures to reduce deaths. Without these, experts warn, the UK will continue to see record drug deaths.
Behind the statistics are thousands of individual tragedies. Families lose loved ones. Children grow up without parents. Communities are devastated by overdose epidemics.
Sarah, a mother from Manchester, lost her son to a nitazene overdose in 2023. He was 28 and had been in recovery for two years before relapsing. "He thought he was buying heroin," she said. "He didn't know it was laced with something 500 times stronger. He was dead within minutes. If there had been a safe place to use, or a way to test what he was taking, he might still be alive."
James, a former heroin user from Glasgow, survived multiple overdoses before getting into treatment. "I lost count of how many friends I've lost," he said. "The system is broken. You wait months for rehab, and by the time a place comes up, you've relapsed or died. We need more treatment, more support, and we need to stop treating drug users like criminals."
Drug-related deaths in England and Wales reached 5,448 in 2023, the highest on record, driven by opioids (particularly synthetic opioids like fentanyl and nitazenes) and cocaine. Scotland's drug death rate remains the highest in Europe at 277 per million. Treatment services have been cut by 30% in real terms since 2010, leaving only half of people with opioid dependence in treatment. Harm reduction measures proven to save lives—supervised consumption rooms, drug checking services, expanded naloxone distribution—remain illegal or severely restricted.
The government has announced £532 million over three years to rebuild treatment capacity, but experts estimate the UK needs an additional £1 billion per year to provide adequate services. Without urgent investment in treatment and harm reduction, and a shift from criminalisation to a public health approach, the UK faces an American-style opioid epidemic with thousands more preventable deaths. The crisis is not inevitable—it is a policy choice. Other countries have shown that evidence-based harm reduction and treatment can save lives. The question is whether the UK will act before more lives are lost.